Evidence map›Paper›PMID 36900143›Full record

ArticleDiagnostics (Basel, Switzerland)2023

The Prevalence and Risk Factors of Chronic Heart Failure in the Mongolian Population.

Pagmadulam Sukhbaatar, Batzorig Bayartsogt, Ganchimeg Ulziisaikhan, Bolortuul Byambatsogt, Chingerel Khorloo, Burmaa Badrakh, Sumiya Tserendavaa, Naranchimeg Sodovsuren, Mungunchimeg Dagva, Mungun-Ulzii Khurelbaatar and 4 more

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pagmadulam SukhbaatarDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.ORCID 0000-0003-3055-4031
Batzorig BayartsogtDepartment of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Ganchimeg UlziisaikhanNational Cardiovascular Center of Mongolia, The Third State Central Hospital, Ulaanbaatar 16081, Mongolia.
Bolortuul ByambatsogtDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Chingerel KhorlooDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Burmaa BadrakhDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Sumiya TserendavaaDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.ORCID 0000-0002-8255-6955
Naranchimeg SodovsurenDepartment of Communication Skill, Bio-Medical School, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Mungunchimeg DagvaNational Cardiovascular Center of Mongolia, The Third State Central Hospital, Ulaanbaatar 16081, Mongolia.
Mungun-Ulzii KhurelbaatarCardiac Rhythmology Center of the Third State Central Hospital Mongolia, Ulaanbaatar 16081, Mongolia.
Sodchimeg TsedensodnomNobel Pharmaceutical Company, Ulaanbaatar 16100, Mongolia.
Bat-Erdene NyamsurenDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Rinchyenkhand MyagmardorjCardiovascular Department, University Hospital of Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.ORCID 0000-0002-6544-1777
Tsolmon UnurjargalDepartment of Cardiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.ORCID 0000-0002-6682-0023

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of heart failure in the Mongolian population is unknown. Thus, in this study, we aimed to define the prevalence of heart failure in the Mongolian population and to identify significant risk factors for heart failure among Mongolian adults.

methodsThis population-based study included individuals 20 years and older from seven provinces as well as six districts of the capital city of Mongolia. The prevalence of heart failure was based on the European Society of Cardiology diagnostic criteria.

resultsIn total, 3480 participants were enrolled, of which 1345 (38.6%) participants were males, and the median age was 41.0 years (IQR 30-54 years). The overall prevalence of heart failure was 4.94%. Patients with heart failure had significantly higher body mass index, heart rate, oxygen saturation, respiratory rate, and systolic/diastolic blood pressure than patients without heart failure. In the logistic regression analysis, hypertension (OR 4.855, 95% CI 3.127-7.538), previous myocardial infarction (OR 5.117, 95% CI 3.040-9.350), and valvular heart disease (OR 3.872, 95% CI 2.112-7.099) were significantly correlated with heart failure.

conclusionsThis is the first report on the prevalence of heart failure in the Mongolian population. Among the cardiovascular diseases, hypertension, old myocardial infarction, and valvular heart disease were identified as the three foremost risk factors in the development of heart failure.

Indexed as

diagnostic criteriaheart failureprevalencerisk factor

Identifiers

PMID36900143
PMCPMC10000622

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read101
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.